Stay updated on Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial

Sign up to get notified when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Removal of the government funding status banner; core study details, eligibility criteria, and locations remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T06:24:33.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The screenshots show the same Study Details page with no substantive changes to core study information (title, conditions, endpoints, eligibility, enrollment, locations); only visual layout differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:05:51.000Z thumbnail image
  4. Check
    49 days ago
    Change Detected
    Summary
    Major update: system notice about funding/operating status and a version bump to v3.2.0 (replacing v3.1.0).
    Difference
    3%
    Check dated 2025-10-05T09:26:21.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The core page content shifts to the newer release identifier; no other substantive content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-28T03:07:46.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-13T16:52:36.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T14:26:33.000Z thumbnail image

Stay in the know with updates to Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.